M. Paesmans

Response to chemotherapy, quality of life benefits and survival in advanced non-small cell lung cancer: review of literature results.

M. Paesmans, J. Klastersky, J. Klastersky, 2001, Lung cancer.

A three-arm phase III randomised trial comparing combinations of platinum derivatives, ifosfamide and/or gemcitabine in stage IV non-small-cell lung cancer.

J. Lafitte, V. Ninane, M. Paesmans, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

CYFRA 21-1 is a prognostic determinant in non-small-cell lung cancer: results of a meta-analysis in 2063 patients

M Paesmans, O. Molinier, M. Paesmans, 2004, British Journal of Cancer.

Preoperative treatment with mFOLFIRINOX or Gemcitabine/Nab-paclitaxel +/- isotoxic high-dose stereotactic body Radiation Therapy (iHD-SBRT) for borderline resectable pancreatic adenocarcinoma (the STEREOPAC trial): study protocol for a randomised comparative multicenter phase II trial

I. Borbath, J. Van Laethem, K. Geboes, 2023, BMC Cancer.

First-in-human study of SBRT and adenosine pathway blockade to potentiate the benefit of immunochemotherapy in early-stage luminal B breast cancer: results of the safety run-in phase of the Neo-CheckRay trial

L. Buisseret, M. Ignatiadis, L. Craciun, 2023, Journal for ImmunoTherapy of Cancer.

Multiple-drug weekly chemotherapy versus standard combination regimen in small-cell lung cancer: a phase III randomized study conducted by the European Lung Cancer Working Party.

M. Paesmans, J. Sculier, F. Ries, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Survival is better predicted with a new classification of stage III unresectable non-small cell lung carcinoma treated by chemotherapy and radiotherapy.

T. Berghmans, J. Sculier, G. Koumakis, 2004, Lung cancer.

[VEGF and survival of patients with lung cancer: a systematic literature review and meta-analysis].

J. Verdebout, J. Lafitte, M. Paesmans, 2002, Revue des maladies respiratoires.

Summary report of the Standards, Options and Recommendations for the management of patients with non-small-cell lung carcinoma (2000)

E. Touboul, T. Molina, E. Lemarié, 2003, British Journal of Cancer.

A three-arm phase III randomised trial assessing, in patients with extensive-disease small-cell lung cancer, accelerated chemotherapy with support of haematological growth factor or oral antibiotics

J. Lafitte, V. Ninane, M. Paesmans, 2001, British Journal of Cancer.

A comparison of methods of calculation for estimating carboplatin AUC with a retrospective pharmacokinetic-pharmacodynamic analysis in patients with advanced non-small cell lung cancer. European Lung Cancer Working Party.

J. Lafitte, V. Ninane, M. Paesmans, 1999, European journal of cancer.